Breaking News
January 22, 2019 - Blood marker could aid in early prediction of Alzheimer’s progression
January 22, 2019 - Orthodontic treatment does not guarantee future dental health
January 22, 2019 - Rutgers researchers discover cause of bone loss in people with joint replacements
January 22, 2019 - Diversity among rural Africans extends to their gut microbiomes
January 22, 2019 - Newly developed biological system lets cells to create self-curving cornea
January 22, 2019 - VTv Therapeutics Announces Publication of Comprehensive Data in Science Translational Medicine Detailing the Discovery and Clinical Development of TTP399, including Results of Phase 2 AGATA Study
January 22, 2019 - about one in three adults with prediabetes has arthritis
January 22, 2019 - A look at how data is democratizing health care
January 22, 2019 - Alcohol-Linked Disease Overtakes Hep C As Top Reason For Liver Transplant
January 22, 2019 - Researchers identify new genes linked with age-related macular degeneration
January 22, 2019 - MPFI researchers identify synaptic logic for connections between two brain hemispheres
January 22, 2019 - New study extends our knowledge of the link between miRNAs and cancer
January 22, 2019 - Genetic changes may predict likelihood of relapse in breast cancer patients
January 22, 2019 - Antiepileptic drug use by people with Alzheimer’s disease linked to accumulation of hospital days
January 22, 2019 - IUPUI researcher receives $2.85 million grant to find ways to improve bone strength
January 22, 2019 - Precision medicine can help keep astronauts healthy during deep space missions
January 22, 2019 - Detecting signs of neurodegeneration earlier and more accurately
January 22, 2019 - Mouse studies challenge ‘inhibition’ theory of autism
January 22, 2019 - SSB launches BIOSTAT RM TX single-use bioreactor for producing consistent quality cellular products
January 22, 2019 - Experimental drug can positively modify key characteristic behavior in FXS patients
January 22, 2019 - Low-Income Women Lack Menstrual Hygiene Supplies
January 22, 2019 - Better mouse model built to enable precision-medicine research for Alzheimer’s
January 22, 2019 - Molecular profiling of precancerous lung lesions could lead to early detection and new treatments
January 22, 2019 - Genetic factors influence where fat is stored in our bodies
January 22, 2019 - The Psychology Behind Sticking to Your New Year’s Resolutions
January 22, 2019 - Scientists aim to find genetic causes of developmental abnormalities in the vagina and uterus
January 22, 2019 - New survey reveals scale of preventative healthcare challenge in the UK
January 22, 2019 - Looming Global Crisis Means People’s Diets Must Change: Experts
January 22, 2019 - Excessive social media use is comparable to drug addiction
January 22, 2019 - Researchers show how mechanical stress affects bone development
January 22, 2019 - Study takes a step closer to understanding the body’s response to opioid painkillers
January 22, 2019 - Unexpected connection found between feeding and memory centers of the brain
January 22, 2019 - A revolutionary approach transforms bone trauma treatment
January 22, 2019 - Early studies and recent clinical trials on nerve growth factor
January 22, 2019 - Dry Mouth and Older Adults: Information for Caregivers
January 22, 2019 - Are your grandparents getting tipsy at the holiday party?
January 22, 2019 - New machine learning algorithms identify early symptoms of urinary tract infections
January 22, 2019 - Young women skipping the Pap smear test due to embarrassment
January 22, 2019 - A global influenza pandemic high on the WHO’s agenda
January 22, 2019 - Amgen Makes All Repatha (evolocumab) Device Options Available In The US At A 60 Percent Reduced List Price
January 22, 2019 - Elastronics—hydrogel-based microelectronics for localized low-voltage neuromodulation
January 22, 2019 - Branched-chain amino acids in tumors can be targeted to prevent and treat cancer
January 22, 2019 - Fueling macrophages with energy to attack and eat cancer cells
January 22, 2019 - Amgen And UCB Receive Positive Vote From FDA Advisory Committee In Favor Of Approval For Evenity (romosozumab)
January 22, 2019 - Does being bilingual make children more focused? Study says no
January 22, 2019 - Study reveals new genes and biological pathways linked to osteoarthritis
January 22, 2019 - FSU study provides better understanding of spinal cord injuries
January 22, 2019 - Delaying bath for newborn babies increases breastfeeding rates, finds study
January 21, 2019 - WHO identifies non-communicable diseases as major threat to human health
January 21, 2019 - Many parents still try non-evidence-based cold prevention methods for children
January 21, 2019 - High Levels of Activity, Motor Ability Linked to Better Cognition
January 21, 2019 - Killer blows? Knockout study of pair of mouse MicroRNA provides cancer insight
January 21, 2019 - Buffalo researchers receive grant to quicken development of generic equivalents of contraceptives
January 21, 2019 - One-third of pregnant women do not believe cannabis is harmful to their fetus
January 21, 2019 - Fiderstat could be used as chemopreventative drug for intestinal cancers caused by APC gene mutations
January 21, 2019 - Modifying healthcare delivery practices may improve discussions between youth and healthcare providers
January 21, 2019 - UNIST researcher named as recipient of Merck’s 2018 Life Science Awards
January 21, 2019 - How Getting a Flu Shot Could Save Your Life
January 21, 2019 - Surgical adhesions can be treated, prevented in mice
January 21, 2019 - Increased physician-targeted marketing associated with higher opioid overdose deaths
January 21, 2019 - Researchers uncover specific microbial signatures of intestinal disease
January 21, 2019 - Researchers discover new blood vessel system in bones
January 21, 2019 - Simple blood test reliably detects signs of Alzheimer’s damage before symptoms
January 21, 2019 - Study to investigate new targeted oral treatments for severe asthma
January 21, 2019 - Plan Your Plate | NIH News in Health
January 21, 2019 - Fecal occult blood test may improve CRC outcomes in some
January 21, 2019 - Blood test detects Alzheimer’s disease years before symptoms develop
January 21, 2019 - Mount Sinai joins with Paradigm and ReqMed to repurpose drug for treatment of MPS
January 21, 2019 - FDA Advisory Committee Votes on Zynquista (sotagliflozin) as Treatment for Adults with Type 1 Diabetes
January 21, 2019 - The causes and complications of snoring
January 21, 2019 - Placenta adapts and compensates when pregnant mothers have poor diets or low oxygen
January 21, 2019 - New implant could restore the transmission of electrical signals in injured central nervous system
January 21, 2019 - Rapid-acting fentanyl test strips found to be effective at reducing overdose risk
January 21, 2019 - Coronary Artery Calcium May Help Predict CVD in South Asians
January 21, 2019 - The mystery of the super-ager
January 21, 2019 - Scientists develop smart microrobots that can change shape depending on their surroundings
January 21, 2019 - Keep Moving to Keep Brain Sharp in Old Age
January 21, 2019 - Despite progress, gay fathers and their children still structurally stigmatized
January 21, 2019 - New drug for treating liver parasites in vivax malaria
January 21, 2019 - Merck recognized with 2018 Life Science Industry Award for best use of social media
Pfizer to launch own little white pill

Pfizer to launch own little white pill

image_pdfDownload PDFimage_print
Viagra goes generic: Pfizer to launch own little white pill
This Monday, Dec. 4, 2017 photo shows a tablet of Pfizer’s Viagra, left, and the company’s generic version, sildenafil citrate, at Pfizer Inc., headquarters in New York. The drugmaker is launching its own cheaper generic version of Viagra rather than lose sales when its impotence pill gets its first generic competition. (AP Photo/Richard Drew)

The little blue pill that’s helped millions of men in the bedroom is turning white. Drugmaker Pfizer is launching its own cheaper generic version of Viagra rather than lose most sales when the impotence pill gets its first generic competition next week.

Pfizer Inc. will begin selling the white pill at half the $65-a-pill retail price on Monday, when its patent-protected monopoly ends. Generic maker Teva Pharmaceuticals can start selling its version then, but isn’t disclosing the price.

Many more generics go on sale next summer, which will steadily slash the price of generics, possibly by 90 percent.

“Patients are paying fortunes. When generic Viagra comes out, they will be very happy,” said Dr. Nachum Katlowitz, a urologist at New York’s Staten Island University Hospital.

Launched in 1998, Viagra was the first pill for impotence. It transformed a private frustration for many aging men into a publicly discussed medical condition with an easy treatment, far more appealing than options like penile injections and implants. Pfizer’s early TV ads for the little blue pill even coined the term erectile dysfunction, ED for short.

Eli Lilly’s Cialis came out in 2003 and now dominates the U.S. market with on-demand pills and daily, low-dose ones. Viagra is a close second.

Viagra goes generic: Pfizer to launch own little white pill
This Monday, Dec. 4, 2017 photo shows Pfizer’s Viagra, left, and the company’s generic version, sildenafil citrate, at Pfizer Inc., headquarters in New York. The drugmaker is launching its own cheaper generic version of Viagra rather than lose sales when its impotence pill gets its first generic competition. (AP Photo/Richard Drew)

Pfizer says its market research shows 20 percent of customers are loyal to Viagra. So rather than give up sales to generic makers as brand-name drugmakers once routinely did, the company is selling its own generic and also fighting to keep men on its blue pills.

“We believe that the story for Viagra isn’t done. It’s just going to be a new chapter,” said Jim Sage, president of U.S. brands for Pfizer Essential Health, which sells its older medicines.

In January, the drugmaker will offer two new discount programs and increase its copayment card discounts. Uninsured men can get brand-name Viagra half off through an innovative online home delivery program, Pfizer Direct. Many insured patients will be able to get a month’s prescription—typically six to 10 pills, depending on plan limits—for as little as a $20 copayment.

“This is the most comprehensive pricing and marketing response I’ve seen to a generic,” said Erik Gordon, a pharmaceuticals analyst at the University of Michigan’s business school. “It’s unprecedented.”

Gordon thinks Pfizer’s reduced prices will retain some patients and attract others who buy pills, often counterfeits, from the internet.

Viagra goes generic: Pfizer to launch own little white pill
In this Dec. 1, 2017 photo, patient Daniel Lobello, left, speaks with Dr. Matthias Hofer, a urologist at Northwestern Memorial Hospital in Chicago. Lobello, 60, thinks a lot of men probably would start using cheaper generic or brand-name Viagra. “It’s great” that the prices are getting cut, said the electrical inspector, “because it’s something men need.” (AP Photo/Teresa Crawford)

Dr. Matthias Hofer, a urologist at Northwestern Memorial Hospital in Chicago, said some of his insured patients who take Viagra wouldn’t want a generic. “They will be ecstatic if they can save money and get the brand product from Pfizer,” he said.

Last year, more than 12 million prescriptions for Viagra and Cialis were filled in the U.S., generating a combined $3 billion in sales, according to health data and clinical research company IQVIA. However, prescriptions have dropped more than 20 percent since 2012, as repeated price hikes put the pills out of reach for many men lacking good insurance.

According to health information analytics firm Elsevier, over just the past decade, retail prices jumped from about $10 to $62 per pill for Viagra and from $11 to $61 for Cialis. Pharmacies and other middlemen add a few dollars more per pill.

Generic Viagra, called sildenafil, will become even more affordable starting June 11, when more versions go on sale.

“Many patients already know it’s going generic and they want it,” said Aracely Pena, a medical assistant at San Diego Sexual Medicine.

Viagra goes generic: Pfizer to launch own little white pill
This Dec. 1, 2017 photo, shows Dr. Matthias Hofer, a urologist at Northwestern Memorial Hospital in Chicago. Hofer says he has some insured patients taking Viagra who wouldn’t want a generic. “They will be ecstatic if they can save money and get the brand product from Pfizer,” he said, adding that half his patients can’t afford Viagra and some just go without sex.(AP Photo/Teresa Crawford)

Cialis and Levitra, another pill launched in 2003, get their own generic competition next fall.

In the meantime, some doctors specializing in sexual dysfunction have found other options. Some prescribe generic Revatio, the blood pressure pill Pfizer was testing when older patients reported stronger erections as a side effect. It contains one-fifth the sildenafil dose in Viagra and costs as little as $1 per pill.

Northwestern’s Hofer arranges for his patients to receive made-to-order pills from a couple of specialty pharmacies.

Viagra goes generic: Pfizer to launch own little white pill
This Monday, Dec. 4, 2017 photo shows Pfizer’s generic version of Viagra, sildenafil citrate, at the company’s headquarters in New York. The drugmaker is launching its own cheaper generic version of Viagra rather than lose sales when its impotence pill gets its first generic competition. (AP Photo/Richard Drew)

Daniel Lobello, 60, is satisfied with those pills but thinks a lot of men probably would use cheaper generic or brand-name Viagra.

“It’s great” that the prices are getting cut, said the West Chester, Illinois, electrical inspector, “because it’s something men need.”


Explore further:
Pfizer, Teva reach deal to allow generic Viagra

Tagged with:

About author

Related Articles